S Ménard Selected Research

S Ménard Research Topics

Disease

17	Neoplasms (Cancer) 05/2014 - 01/2000
15	Breast Neoplasms (Breast Cancer) 08/2013 - 01/2000
3	Necrosis 06/2004 - 06/2002
2	Carcinoma (Carcinomatosis) 05/2004 - 01/2000
1	Dysbiosis 10/2018
1	Inflammation (Inflammations) 10/2018
1	Colitis 10/2018
1	Hypersensitivity (Allergy) 10/2018
1	Fetal Macrosomia 02/2017
1	Cardiotoxicity 08/2013
1	Neoplasm Metastasis (Metastasis) 08/2013
1	Disease Progression 08/2013
1	Human Influenza (Influenza) 01/2004
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2003
1	Mucositis 12/2001
1	Drug-Related Side Effects and Adverse Reactions 12/2001
1	Prostatic Neoplasms (Prostate Cancer) 11/2001
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2001
1	Carcinogenesis 10/2000
1	Lung Neoplasms (Lung Cancer) 10/2000
1	Tuberculosis (Tuberculoses) 07/2000
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2000

Drug/Important Bio-Agent (IBA)

4	Tamoxifen FDA LinkGeneric 01/2001 - 01/2000
3	Interleukin-12 (IL 12)IBA 05/2004 - 07/2000
3	Proteins (Proteins, Gene)FDA Link 04/2002 - 01/2000
3	Biological ProductsIBA 01/2001 - 02/2000
3	Hormones (Hormone)IBA 01/2001 - 01/2000
2	Trastuzumab (Herceptin)FDA Link 05/2014 - 08/2013
2	Estrogen ReceptorsIBA 08/2013 - 10/2000
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2008 - 06/2002
2	OligonucleotidesIBA 02/2008 - 06/2003
2	Biomarkers (Surrogate Marker)IBA 02/2008 - 01/2001
2	Peptides (Polypeptides)IBA 06/2005 - 10/2000
2	Oncogene Proteins (Oncogene Protein)IBA 12/2004 - 02/2000
2	AntigensIBA 06/2003 - 10/2000
2	Monoclonal AntibodiesIBA 04/2002 - 10/2000
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2001 - 02/2000
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2001 - 02/2000
2	Fluorouracil (Carac)FDA LinkGeneric 01/2001 - 02/2000
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2001 - 02/2000
2	Methotrexate (Mexate)FDA LinkGeneric 01/2001 - 02/2000
1	Interleukin-10 (Interleukin 10)IBA 10/2018
1	Bile Acids and Salts (Bile Acids)IBA 10/2018
1	ProstaglandinsIBA 02/2017
1	Pharmaceutical PreparationsIBA 08/2013
1	Taxoids (Taxanes)IBA 10/2008
1	Estrogens (Estrogen)FDA Link 10/2008
1	Complementary DNA (cDNA)IBA 02/2008
1	Messenger RNA (mRNA)IBA 03/2006
1	laminin 1IBA 06/2005
1	Laminin (Merosin)IBA 06/2005
1	Peptide Hydrolases (Proteases)FDA Link 06/2005
1	Tissue Inhibitor of Metalloproteinase-2IBA 06/2005
1	matrigelIBA 06/2005
1	Laminin ReceptorsIBA 06/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2004
1	Conditioned Culture MediaIBA 06/2004
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2004
1	InterferonsIBA 05/2004
1	CPG-oligonucleotideIBA 05/2004
1	InterleukinsIBA 05/2004
1	Topotecan (Hycamtin)FDA LinkGeneric 05/2004
1	ORALIT (ORS)IBA 01/2004
1	Pattern Recognition ReceptorsIBA 06/2003
1	GuanosineIBA 06/2003
1	CytosineIBA 06/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2001
1	CytokinesIBA 11/2001
1	DNA (Deoxyribonucleic Acid)IBA 11/2001
1	FenretinideIBA 02/2001
1	Indicators and Reagents (Reagents)IBA 01/2001
1	Class 4 Receptor-Like Protein Tyrosine PhosphatasesIBA 10/2000
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 10/2000
1	AcetoneIBA 10/2000
1	AcidsIBA 10/2000
1	MucinsIBA 10/2000
1	VaccinesIBA 07/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2000
1	Nerve Growth Factor (NGF)IBA 02/2000
1	Immunoglobulins (Immunoglobulin)IBA 02/2000
1	AntibodiesIBA 02/2000
1	Tyrosine Kinase InhibitorsIBA 02/2000

Therapy/Procedure

6	Therapeutics 08/2013 - 02/2000
4	Drug Therapy (Chemotherapy) 10/2008 - 01/2001
1	Immunotherapy 05/2004
1	Radical Mastectomy 01/2001
1	Chemoprevention 01/2000